Silence Therapeutics Financial Overview
Silence Therapeutics's market cap is currently $307.49M. The company's EPS TTM is $-0.15; its P/E ratio is -3.89; Silence Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
